Keldsen N, Havsteen H, Vergote I, Bertelsen K, Jakobsen A (). „Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study”. Gynecol. Oncol. 88 (2): 118–22. doi:10.1016/S0090-8258(02)00103-8. PMID12586589.Mentenanță CS1: Utilizează parametrul autori (link)
Malik IA (). „Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer”. Jpn. J. Clin. Oncol. 31 (2): 69–73. doi:10.1093/jjco/hye012. PMID11302345.
drugbank.ca
„Altretamine”. DrugBank - Canadian Institutes of Health Research. Accesat în .
Keldsen N, Havsteen H, Vergote I, Bertelsen K, Jakobsen A (). „Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study”. Gynecol. Oncol. 88 (2): 118–22. doi:10.1016/S0090-8258(02)00103-8. PMID12586589.Mentenanță CS1: Utilizează parametrul autori (link)
Malik IA (). „Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer”. Jpn. J. Clin. Oncol. 31 (2): 69–73. doi:10.1093/jjco/hye012. PMID11302345.